CNSX:CME

CME Group (CME) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.00
CME stock logo

About CME Group Stock (CNSX:CME)

Canadian Metals Inc. engages in the acquisition, exploration, evaluation, and development of mineral properties in Canada. It explores for silica, zinc, polymetallic, gold, and silver ores. Canadian Metals Inc. was incorporated in 2012 and is headquartered in Montreal, Canada.

CME Stock News Headlines

The asset beating inflation by 4x
"Trump Loophole" Beats Inflation? Inflation has been out of control for years. Forcing you to work longer and harder for more money that is worth less. By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties.
Cantor's Lutnick Is Ready to Take on the CME
CME Group: A Sleep Well At Night Company To Own
The asset beating inflation by 4x
"Trump Loophole" Beats Inflation? Inflation has been out of control for years. Forcing you to work longer and harder for more money that is worth less. By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties.
CME Mar 2024 215.000 put
CME Apr 2024 250.000 call
See More Headlines
Receive CME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CME Group and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Other Industrial Metals & Mining
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
4,370
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$4.00
High Stock Price Target
$4.00
Low Stock Price Target
$4.00
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Beat Frei
    VP of Development & Project Finance , Interim President and CEO
  • Mr. Arnab Kumar De A.C.M.A.
    C.M.A., C.P.A., CGMA, M.B.A., Chief Financial Officer

CME Stock Analysis - Frequently Asked Questions

Should I buy or sell CME Group stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" CME shares.
View CME analyst ratings
or view top-rated stocks.

What is CME Group's stock price target for 2024?

1 Wall Street analysts have issued 1 year target prices for CME Group's stock. Their CME share price targets range from $4.00 to $4.00. On average, they expect the company's share price to reach $4.00 in the next year.
View analysts price targets for CME
or view top-rated stocks among Wall Street analysts.

What other stocks do shareholders of CME Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CME Group investors own include Blueberries Medical (BBM), BioMarin Pharmaceutical (BMRN), nLIGHT (LASR), McDermott International (MDR), Avon Products (AVP), Aurinia Pharmaceuticals (AUPH), Astronics (ATRO), Archrock (AROC), Apollo Global Management (APO) and

How do I buy shares of CME Group?

Shares of CME stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (CNSX:CME) was last updated on 5/5/2024 by MarketBeat.com Staff

From Our Partners